» Articles » PMID: 19296936

Serologic Markers of Autoimmunity in Women with Polycystic Ovary Syndrome

Overview
Journal Fertil Steril
Date 2009 Mar 20
PMID 19296936
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate whether women with the polycystic ovary syndrome (PCOS) have an increased rate of elevated serum levels of common autoimmunologic parameters.

Design: Prospective case-control study.

Setting: Academic research institution.

Patient(s): One hundred nine women with PCOS and 109 age-matched healthy controls.

Intervention(s): Peripheral venous puncture, ultrasonography, questionnaire.

Main Outcome Measure(s): Serum levels of antinuclear antibodies (ANAs) were measured by immunometric enzyme immunoassay, serum levels of IgG class autoantibodies against histone, IgG class autoantibodies against nucleosomes, and IgG class autoantibodies against double-stranded (ds) DNA were measured by enzyme immunoassays.

Result(s): Women with PCOS had significantly elevated serum levels of antihistone and anti-dsDNA antibodies, whereas serum levels of ANAs and antinucleosome antibodies were similar between the two groups. When serum levels of ANAs, antihistone, antinucleosomes, and anti-dsDNA antibodies were correlated with clinical and biochemical parameters, a significant correlation between serum levels of ANAs and serum TSH was established.

Conclusion(s): Our study shows that serologic parameters of autoimmunity (i.e., antihistone and anti-dsDNA antibodies) are elevated in women with PCOS. A role of autoimmunologic processes in PCOS can be suspected.

Citing Articles

The prevalence of autoimmune thyroiditis is not increased in women with polycystic ovary syndrome after adjustment for family predisposition.

Vryonidou A, Mizamtsidi M, Palioura E, Kalogeris N, Vassilatou E, Ioannidis D Endocrine. 2025; .

PMID: 39883390 DOI: 10.1007/s12020-025-04181-3.


Association Between Serum Antinuclear Antibody and Polycystic Ovarian Syndrome in Reproductive Women Aged 18 to 35 Years: A Quest for an Autoimmune Marker.

Shrivastava C, Sagiraju P, Rajbhar S, Bansal R, Kodumuri L Cureus. 2025; 16(12):e75224.

PMID: 39759697 PMC: 11700530. DOI: 10.7759/cureus.75224.


Unveiling the link: anti-protein disulfide isomerase A3 autoantibody expression and polycystic ovary syndrome risk in euthyroid autoimmune thyroiditis women.

Chen Z, Zhang C, Meng C, Hu Y, Niu Y, Gao B J Ovarian Res. 2024; 17(1):247.

PMID: 39702372 PMC: 11656784. DOI: 10.1186/s13048-024-01569-z.


An Atypical Case of Polycystic Ovarian Syndrome and Possible Newly Diagnosed Systemic Lupus Erythematosus Complicated With a Cerebrovascular Accident in a Young Female: A Case Report.

Arrey Agbor D, Ugwendum D, Sivasubramanian B, Ojwaka M, Forsah S, Gold-Olufadi S Cureus. 2024; 16(2):e54163.

PMID: 38496063 PMC: 10941230. DOI: 10.7759/cureus.54163.


Causal association of immune cells and polycystic ovarian syndrome: a Mendelian randomization study.

Aru N, Yang C, Chen Y, Liu J Front Endocrinol (Lausanne). 2024; 14:1326344.

PMID: 38189053 PMC: 10770856. DOI: 10.3389/fendo.2023.1326344.